Key facts
- This page summarizes Shashikant Kulkarni's Form 4 filing for NEOGENOMICS INC (NEO).
- 1 reported transaction and 2 derivative rows are listed below.
- Accepted by SEC: 04 Apr 2023, 17:04.
Shashikant Kulkarni - 01 Apr 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- NEO
- Reported as of
- 01 Apr 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Apr 2023, 17:04:49 UTC
- Prior SEC filing
- 03 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ali Olivo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Shashikant Kulkarni filed Form 4 for NEOGENOMICS INC (NEO) on 04 Apr 2023.
Change
- Previous filing in this sequence was filed on 03 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Tax liability
- Transaction value
- $0
- Shares
- -3,759
- Change %
- -4.3%
- Price
- $0.000000
- Shares after
- 82,673
- Date
- 01 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 132,744
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 132,744
- Exercise price
- $12.15
- Footnotes
- F2
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 51,653
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,653
- Exercise price
- $10.12
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the April 1, 2023 vesting of restricted stock.
Footnote F2
On April 1, 2022, Dr. Kulkarni was granted 132,744 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F3
On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.